Reversible change from one cell type to another is known as -
During cell death, myelin figures are derived from which of the following?
What is the definition of lipofuscin?
Which molecule is primarily responsible for nuclear fragmentation during apoptosis?
Which of the following is not considered an example of excess tissue growth?
Which of the following is derived from fibroblast cells?
Which of the following cellular changes is reversible?
Fat necrosis is most commonly associated with which of the following?
Hypertrophy is -
Which type of necrosis is most commonly associated with the spread of infection?
Explanation: ***Metaplesia*** - Refers to the **reversible change** from one cell type to another in response to chronic irritation or damage [1][2]. - It often occurs as an adaptive response in **epithelial tissues**, such as in the respiratory tract in smokers [1][2]. *Hypertrophy* - Represents an **increase in cell size** rather than a change in cell type [2]. - It is often a response to increased functional demand, as seen in **cardiac muscle** in athletes. *Hyperplesia* - Refers to an **increase in cell number** within a tissue or organ, not a change in cell type [2]. - Common in conditions such as **benign prostatic hyperplasia** but does not involve differentiation into other cell types. *Dysplasia* - Indicates an **abnormal growth or development** of cells, leading to disordered morphology rather than a transformation into another cell type. - It is often a precursor to cancer but does not signify the reversible nature of metaplasia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 49. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-92.
Explanation: ***Cell membrane (lipid bilayer)*** - **Myelin figures** are whorled phospholipid masses formed during cell injury and death from the breakdown of **cellular membranes**, particularly the plasma membrane and **endoplasmic reticulum**. - These structures represent damaged membrane lipids (phospholipids) that undergo structural rearrangement into concentric lamellar (layered) configurations resembling myelin. - The term "cell membrane" encompasses both the plasma membrane and lipid-rich intracellular membranes, making this the most accurate answer among the options provided. - They are a characteristic morphologic feature of **irreversible cell injury** and can be seen with electron microscopy. *Cytoplasmic components* - While cytoplasmic proteins and organelles do degrade during cell death, they do not form the organized **phospholipid structures** characteristic of myelin figures. - Cytoplasmic breakdown produces different morphologic changes such as cytoplasmic eosinophilia and loss of ribosomes. *Mitochondrial structures* - Mitochondria have their own membranes that are damaged during cell death (leading to release of cytochrome c and other apoptotic factors). - However, mitochondrial membranes are not the primary source of **myelin figures**, which predominantly arise from ER and plasma membranes. *Nuclear membrane* - The nuclear envelope does fragment during cell death, contributing to nuclear changes like **karyopyknosis, karyorrhexis, and karyolysis**. - While technically a membrane structure, the nuclear envelope is not the primary source of myelin figures, which are mainly derived from the more abundant plasma and ER membranes.
Explanation: ***Wear and tear pigment*** - Lipofuscin is known as **wear and tear pigment** that accumulates in cells over time, especially in aging cells [1]. - It is a byproduct of **cellular lipid peroxidation** and protein degradation, indicative of oxidative stress [1]. *Form of calcification* - Not to be confused with calcification, lipofuscin is a **pigment** and not related to calcium deposition [1]. - Calcification usually occurs in response to tissue injury or necrosis, which differs fundamentally from lipofuscin accumulation. *Fat deposits* - Lipofuscin is made up of **an insoluble complex** and is not classified simply as fat or fat deposits [1]. - It is the result of the **degradation of cellular components**, rather than the accumulation of unutilized fats [1]. *Blood pigment* - Lipofuscin is not derived from **hemoglobin** or any blood components, distinguishing it from true blood pigments like **bilirubin**. - It is associated with **cellular aging** rather than with any specific blood function or metabolism [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 75-77.
Explanation: ***Caspases*** - **Caspases** are a family of proteases that play a central role in the execution phase of apoptosis, including the **cleavage of nuclear proteins** and DNA fragmentation [1]. - Specifically, **executioner caspases** (e.g., caspase-3, -6, -7) activate **CAD (caspase-activated DNase)** by cleaving its inhibitor ICAD, leading to **nuclear fragmentation** and DNA laddering [1]. - This is the **primary mechanism** of nuclear breakdown in apoptosis. *Apaf-1* - **Apaf-1 (apoptotic protease activating factor 1)** is an adaptor protein that, upon activation by cytochrome c, forms the **apoptosome** [1]. - While essential for **caspase activation** (specifically caspase-9), Apaf-1 does not directly cleave nuclear components or cause fragmentation itself [1]. *Oxygen free radicals* - **Oxygen free radicals** (reactive oxygen species) can induce cellular damage and stress, and in high concentrations, can trigger apoptosis [2]. - However, they are generally upstream initiators of apoptosis pathways and do not directly mediate nuclear fragmentation; this process is carried out by **caspases**. *Endonuclease G* - **Endonuclease G** is a mitochondrial nuclease released during apoptosis that can contribute to DNA degradation. - However, it plays a **secondary role** and acts in a caspase-independent manner, whereas **caspases** remain the primary executors of nuclear fragmentation in apoptosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-67. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 100-101.
Explanation: ***Granulation tissue*** - Granulation tissue is a normal part of the healing process and does not represent an **excessive growth** of tissue [3]. - It consists mainly of **new connective tissue** and blood vessels formed during healing, rather than a pathological proliferation [3]. *Hyperplasia* - Hyperplasia is characterized by an **increase in the number** of cells in a tissue, leading to tissue enlargement [1][2]. - This process is often a response to a stimulus, such as hormonal changes or injury, indicating **excess tissue growth** [2]. *Neoplasia* - Neoplasia refers to the **abnormal proliferation** of cells, forming a neoplasm or tumor, which can be benign or malignant. - This is a clear example of **excess tissue growth**, as it involves uncontrolled cell division. *Fibrosis* - Fibrosis implies the formation of excess **fibrous connective tissue**, leading to a stiff or thickened tissue, signifying abnormal tissue growth [4]. - It often results from chronic inflammation or injury, again reflecting **excessive tissue** formation [4]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 87-88. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-87. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 105-106. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 111-112.
Explanation: ***Collagen*** - Collagen is a structural protein that is predominantly produced by **fibroblast cells** in the extracellular matrix [1][2]. - It provides tensile strength and structural support to various tissues, playing a crucial role in wound healing and tissue repair [2]. *TGF-13* - Transforming Growth Factor-beta 1 (TGF-β1) is primarily produced by **immune cells** and is involved in cell growth and differentiation, not primarily by fibroblasts. - It plays a role in **fibrosis** and inflammation, but is not directly synthesized by fibroblast cells themselves. *MMP2* - Matrix Metalloproteinase-2 (MMP-2) is produced by various cell types, including **endothelial and epithelial cells**, but not predominantly by fibroblasts. - It is involved in the degradation of **extracellular matrix** components rather than being a product of fibroblast synthesis. *Angiopoietin* - Angiopoietin is primarily secreted by **endothelial cells** and plays a significant role in blood vessel formation and maturation. - It is not derived from fibroblast cells and is unrelated to their primary function of producing the extracellular matrix. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 31-32. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 34-35.
Explanation: ***Bleb formation*** - **Bleb formation** is a reversible cellular injury process, typically indicating the cell is under stress but not necessarily dead [1,3]. - This process can be a result of **cell swelling**, often due to acute cell injury, which can resolve if the stressor is removed [2,4]. *Karyolysis* - **Karyolysis** refers to the dissolution of the cell nucleus, often indicating irreversible injury leading to cell death (necrosis) [1]. - This process is often associated with **loss of nuclear material**, which is not reversible [1]. *Pyknosis* - **Pyknosis** signifies nuclear condensation and is typically an irreversible process, indicating that the cell is undergoing necrosis [1]. - Cells with **pyknosis** have lost their viability and will not return to a healthy state [1]. *Pyknosis* - As mentioned, **pyknosis** indicates nuclear shrinkage and is an irreversible change, consistent with cell death [1]. - It is a common finding in **necrotic cells**, further demonstrating its non-reversible nature [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 53. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 49-50. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 53-55. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 51-53.
Explanation: ***Correct: Retroperitoneal fat*** - **Fat necrosis is most commonly associated with acute pancreatitis**, where activated pancreatic enzymes (lipases) leak into surrounding tissues and digest retroperitoneal and peripancreatic fat - This is termed **enzymatic fat necrosis** or **steatonecrosis**, characterized by the formation of **calcium soaps (saponification)** - a pathognomonic feature - Clinically presents with elevated amylase/lipase, severe epigastric pain radiating to the back, and **Cullen's sign** (periumbilical ecchymosis) or **Grey Turner's sign** (flank ecchymosis) in severe cases - This is the **classic and most frequently cited example** of fat necrosis in pathology textbooks and medical education *Incorrect: Breast tissue* - Fat necrosis does occur in breast tissue, typically following **trauma, surgery, biopsy, or radiation therapy** - Presents as a **painless lump** that can mimic breast cancer on clinical examination and imaging - While common in breast pathology, it is **not the most common cause of fat necrosis overall** when considering systemic pathology - Important differential diagnosis in breast lumps *Incorrect: Omental fat* - Fat necrosis can occur in omental fat, particularly in **omental infarction** or **omental torsion** - Presents with acute abdominal pain and may require surgical intervention - However, this is a relatively **rare condition** compared to pancreatic fat necrosis *Incorrect: None of the options* - This is incorrect because retroperitoneal fat (in the context of acute pancreatitis) is the correct and most common association with fat necrosis
Explanation: ***Increase in cell size*** - **Hypertrophy** is defined as an increase in the **size of individual cells** [1], leading to an increase in the size of the organ or tissue [2]. - This cellular adaptation occurs when cells are subjected to increased workload or demand, such as in **muscle cells** in response to exercise or **cardiac myocytes** in hypertension [2]. *Increase in cell number* - An increase in **cell number** is termed **hyperplasia** [1]. - Hyperplasia typically occurs in tissues capable of **mitotic division**, leading to an increase in the overall size of the tissue or organ due to more cells [1]. *Decrease in cell number* - A decrease in **cell number** can result from **atrophy** (loss of cells) or programmed cell death (**apoptosis**). - This process is seen in various physiological or pathological conditions, leading to a reduction in organ size. *Decrease in cell size* - A decrease in the **size of individual cells** is known as **atrophy** [3]. - Atrophy often occurs due to reduced workload, loss of innervation, diminished blood supply, or inadequate nutrition [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-88. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 45-46. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 90-91.
Explanation: ***Liquifactive necrosis*** - Caused by the enzymatic digestion of tissue, leading to the formation of liquid pus, typically associated with bacterial infections [1]. - Commonly occurs in the **brain** and in a tissue impacted by **pyogenic bacteria** [1], demonstrating how infection can lead to tissue damage. *Fat necrosis* - Primarily related to inflammation of fat tissue, often seen in pancreatitis or trauma to fat areas. - It is not directly caused by infections but rather by fat cell damage and necrosis, leading to **saponification**. *Fibrinoid necrosis* - Associated with **immune-mediated vascular injury**, seen in conditions like **vasculitis** or **malignant hypertension** [2]. - Characterized by the deposition of **fibrin-like protein** [2], not directly related to infectious processes. *Coagulative necrosis* - Typically occurs in ischemic conditions like myocardial infarction, where tissue architecture is preserved despite cell death. - It is not directly linked to infection spread, as it relates more to loss of blood supply rather than infectious agents. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 193-194. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 103-104.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free